3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
11
Phase 1
2
Phase 3
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Breast Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Pancreatic Neoplasms
17
Triple Negative Breast Neoplasms
16
Neoplasm Metastasis
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasms
5
Lung Neoplasms
4
Carcinoma
4
Neoplasms by Site
3
Adenocarcinoma
3
Pancreatic Diseases
2
Ovarian Neoplasms
2
Neoplasms by Histologic Type
2
Fallopian Tube Neoplasms
2
Endocrine System Diseases
2
Endocrine Gland Neoplasms
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Carcinoma, Pancreatic Ductal
2
Carcinoma, Ductal, Breast
2
Vaccinia
1
Thromboembolism
1
Thoracic Neoplasms
1
Squamous Non-Small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Peritoneal Neoplasms
1
Pancreatic cancer, adult
1
Interventions
Cisplatin
47
Radiotherapy
37
Fluorouracil
23
Cetuximab
17
pembrolizumab
11
Carboplatin
11
Paclitaxel
8
Docetaxel
8
Radiotherapy, Intensity-Modulated
6
Chemotherapy, Adjuvant
6
Surgical Procedures, Operative
5
Standard of Care
5
nimotuzumab
4
Methotrexate
4
Gabapentin
4
Drug Therapy
4
Afatinib
4
Radiotherapy, Conformal
3
Radiation
3
Porfiromycin
3
Nivolumab
3
Neoadjuvant Therapy
3
Fibroblast Growth Factor 7
3
Bleomycin
3
zalutumumab
2
sargramostim
2
epacadostat
2
Tranexamic Acid
2
Tirapazamine
2
Pilocarpine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Head and Neck Neoplasms
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts